Here are the five most attractive ASC specialties and some of the attributes that make them appealing platforms, according to the Astor Group's "Investment in the Healthcare Industry" white paper. For a copy of the full report, click here.
ASC Transactions & Valuation Issues
Dawn Q. McLane, RN, MSA, CASC, CNOR, is chief development officer of Nikitis Resource Group, an ASC development and management firm.Q: The number of de novo ASC projects seems to be on the decline. Do you think this is still…
What are ASC management and development companies looking for in ASCs they acquire? Here are five things to know, according to HealthCare Appraisers' 2010 ASC Valuation Survey, which includes responses from 17 organizations representing over 500 surgery centers throughout the…
Cedar Park, Texas, has changed its zoning to allow for the building of a new ASC, according to a Community Impact report.
Valley Surgery Center in Florence, Ala., has had its certificate of need application to expand the types of surgeries offered at the ASC denied by the state's Certificate of Need Review Board, according to a report in The Times Daily.
Dawn Q. McLane, RN, MSA, CASC, CNOR, is chief development officer of Nikitis Resource Group, an ASC development and management firm.Q: There seems to be a decline in the number new surgery centers. What are some of the factors contributing…
Cypress Surgery Center and Visalia Center for Ambulatory Medicine and Surgery, both in Visalia, Calif., will merge their ASCs in August, according to a Visalia Times-Delta report.
Alabama's Medical West, an affiliate of UAB Health System, is considering purchasing the minority ownership stake held by physician investors in the Medical West Ambulatory Surgery Center in Bessemer, Ala., according to the Birmingham Business Journal.
Here are three things to know about the current market for de novo ASCs, according to HealthCare Appraisers' 2010 ASC Valuation Survey, which includes responses from 17 organizations representing over 500 surgery centers throughout the country.
Chris Suscha is vice president of de novo business development for Meridian Surgical Partners.Q: Are you seeing any new trends in the ASC market?
